Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 5, 2009, Pages 321-326

  Noto, D ^a   Cefalu A B ^a   Barbagallo, C M ^a   Sapienza, M ^b   Cavera, G ^b   Nardi, I ^b   Pagano, M ^c   Vivona, N ^c   Notarbartolo, A ^a   Averna, M R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Villa Sofia Hospital   (Italy)

^c AUSL 6   (Italy)

Author keywords

Cardiovascular disease; Elderly; Epidemiology; Risk factors

Indexed keywords

LIPID;

AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; ITALY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SURVIVAL;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; INFLAMMATION; ITALY; LIPIDS; MALE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 67349138790     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.03.002     Document Type: Article

References (22)

1. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
2. Voss R., Cullen P., Schulte H., and Assmann G. Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Münster Study (PROCAM) using neural networks. Int J Epidemiol 31 (2002) 1253-1262
3. Heart Protection Study Collaborative Group. The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial. BMC Med 3 (2005) 6
4. Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Cobbe S.M., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
5. Stork S., Feelders R.A., van den Beld A.W., Steyerberg E.W., Savelkoul H.F., Lamberts S.W., et al. Prediction of mortality risk in the elderly. Am J Med 119 6 (2006) 519-525
6. Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., Venkitachalam L., Kupelian V., Simonsick E.M., et al. Health ABC Study. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111 25 (2005) 3384-3390
7. Strandberg T.E., and Tilvis R.S. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 20 4 (2000) 1057-1060
8. Barbagallo C.M., Cavera G., Sapienza M., Noto D., Cefalù A.B., Polizzi F., et al. Nutritional characteristics of a rural Southern Italy population: the Ventimiglia di Sicilia Project. J Am Coll Nutr 21 6 (2002) 523-529
9. Noto D., Barbagallo C.M., Cavera G., Cefalù A.B., Caimi G., Marino G., et al. Leukocyte count, diabetes mellitus and age are strong predictors of stroke in a rural population in southern Italy: an 8-year follow-up. Atherosclerosis 157 1 (2001) 225-231
10. Barbagallo C.M., Cavera G., Sapienza M., Noto D., Cefalù A.B., Pagano M., et al. Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality: the Ventimiglia di Sicilia project. Int J Obes Relat Metab Disord 25 2 (2001) 185-190
11. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 25 (2002) 3143-3421
12. Rose G.A., Blackburn H., Gillum R.F., and Prineas R.J. Cardiovascular survey methods (1982), World Health Organization, Geneva
13. Walker A.E., Robins M., and Weinfeld F.D. The National Survey of stroke: clinical findings. Stroke 12 suppl 1 pt 2 (1981) I-13-I-44
14. Sans S., Kesteloot H., and Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 18 (1997) 1231-1248
15. Robinson J.G., Bakris G., Torner J., Stone N.J., and Wallace R. Is it time for a cardiovascular primary prevention trial in the elderly?. Stroke 38 2 (2007) 441-450
16. Noto D., Barbagallo C.M., Cefalù A.B., Falletta A., Sapienza M., Cavera G., et al. The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population. Atherosclerosis 197 1 (2008) 147-153
17. Neaton J.D., and Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 152 1 (1992) 56-64
18. Gotto Jr. A.M. The Multiple Risk Factor Intervention Trial (MRFIT). A return to a landmark trial. JAMA 277 7 (1997) 595-597
19. Staessen J.A., Fagard R., Thijs L., Celis H., Arabidze G.G., Birkenhager W.H., et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350 9080 (1997) 757-764
20. Ekbom T., Linjer E., Hedner T., Lanke J., De Faire U., Wester P.O., et al. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Blood Press 13 3 (2004) 137-141
21. Lindholm L.H., Hansson L., Ekbom T., Dahlof B., Lanke J., Linjer E., et al. Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group. J Hypertens 18 11 (2000) 1671-1675
22. Egan B., Gleim G., and Panish J. Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL. Curr Med Res Opin 20 12 (2004) 1909-1917